Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis

被引:60
作者
Bansback, Nick
Marra, Carlo
Tsuchiya, Aki
Anis, Aslam
Guh, Daphne
Hammond, Tony
Brazier, John
机构
[1] St Pauls Hosp, Ctr Hlth Evaluat & Outcomes Sci, Vancouver, BC V6Z 1Y6, Canada
[2] Univ Sheffield, Sheffield, S Yorkshire, England
[3] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[4] Vancouver Coastal Res Inst, Vancouver, BC V5Z 1M9, Canada
[5] Maimonides Hosp, Kent, England
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2007年 / 57卷 / 06期
基金
英国医学研究理事会;
关键词
economics; utility theory; rheumatoid arthritis; quality-adjusted life years;
D O I
10.1002/art.22885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To estimate the relationship between preference-based measures, EuroQol (EQ-5D) and SF-6D, and the Health Assessment Questionnaire (HAQ) disability index (DI) in patients with rheumatoid arthritis (RA), and to characterize components that are predictors of health utility. Methods. Patients with RA participating in 2 studies in the UK (n = 151) and Canada (n = 319) completed the HAQ, EQ-5D, and Short Form 36 (SF-36). The SF-36, a generic measure of quality of life, was converted into the preference-based SF-6D. From these results we developed models of the relationship between the HAQ and SF-6D and EQ-5D using various regression analyses. Results. The optimal model developed for the EQ-5D entered levels for each item as independent variables (model 5). A root mean square error (RMSE) of 0.18 suggested relatively good predictive ability. For the SF-6D, RMSEs were lower (0.09), suggesting better predictions than for the EQ-5D, but models with more explanatory variables did not improve results (model 2 or 4 optimal). The models were able to predict actual SF-6D and EQ-5D across the range of the HAQ DI. Conclusion. Our approach enabled calculations of quality-adjusted life years from existing trials where only the HAQ was measured. All aspects of the HAQ may not be reflected in the preference-based measures, and this method is suboptimal to direct measurement of health state utility in clinical trials. Given this limitation, our approach provides an alternative for researchers who need health-state utility values, but had not included a preference-based measure in their clinical study because of resource constraints or a desire to limit patient burden.
引用
收藏
页码:963 / 971
页数:9
相关论文
共 29 条
[1]  
Barton P, 2004, HEALTH TECHNOL ASSES, V8, P1
[2]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[3]  
Brazier J, 1999, Health Technol Assess, V3, pi
[4]   A comparison of the EQ-5D and SF-6D across seven patient groups [J].
Brazier, J ;
Roberts, J ;
Tsuchiya, A ;
Busschbach, J .
HEALTH ECONOMICS, 2004, 13 (09) :873-884
[5]  
Brazier J., 1999, J Health Serv Res Policy, V4, P174, DOI [10.1177/135581969900400310, DOI 10.1177/135581969900400310]
[6]   Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-lite) instrument from the SF-6D [J].
Brazier, JE ;
Kolotkin, RL ;
Crosby, RD ;
Williams, GR .
VALUE IN HEALTH, 2004, 7 (04) :490-498
[7]   Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK [J].
Brennan, A ;
Bansback, N ;
Reynolds, A ;
Conway, P .
RHEUMATOLOGY, 2004, 43 (01) :62-72
[8]  
BRENNAN A, IN PRESS RHEUMATOLOG
[9]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[10]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108